相关产品推荐更多 >

CIR Antibody - middle region : Biotin 抗体,orb2136113,Biorbyt
¥8216
GNA13 Antibody - N-terminal region : FITC 抗体,orb2090499,Biorbyt
¥8216
Tinto Clusterin/Apolipoprotein J Antibody 抗体,orb1881163,Biorbyt
¥15704
APOE Antibody 抗体,orb1272735,Biorbyt
¥8775
NDUFA6 Antibody - N-terminal region : FITC 抗体,orb2094822,Biorbyt
¥8216
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名:
Phospho-V-Myb+C-Myb (Ser11) Recombinant Rabbit Monoclonal Antibody抗体
- 抗体英文名:
Phospho-V-Myb+C-Myb (Ser11) Recombinant Rabbit Monoclonal Antibody
- 靶点:
MYB
- 浓度:
1mg/ml
- 应用范围:
ICC, IF, IHC-Fr, IHC-P, WB
- 宿主:
Rabbit
- 适应物种:
Human
- 保质期:
6-12个月
- 抗原来源:
详询
- 目录编号:
orb1499349
- 级别:
科研级
- 库存:
88
- 供应商:
biorbyt
- 标记物:
Unconjugated
- 克隆性:
Recombinant
- 保存条件:
参考说明书
- 形态:
Liquid
- 亚型:
IgG
- 免疫原:
KLH conjugated synthesised phosphopeptide derived from human MYB around the phosphorylation site of Ser11
- 规格:
50 ul
别名:Avian myeloblastosis viral(v-myb) oncogene homolog; C myb; c-Myb; MYB_HUMAN; Proto-oncogene c-Myb; Transcriptional activator Myb; v-myb avian myeloblastosis viral oncogene homolog.
免疫原:KLH conjugated synthesised phosphopeptide derived from human MYB around the phosphorylation site of Ser11
分子量:84 kDa
应用稀释比例:WB=1:500-2000, IHC-P=1:100-500, IHC-F=1:100-500, ICC/IF=1:50-200, IF=1:50-200
防腐剂:0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
纯化:Affinity purified by Protein A
保存说明:Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
UniProt ID:P10242
Note:For research use only.


风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验双特异抗体(Bispecific antibody)的简介和制作方法
linker。目前用于该设计方法的linker 有:25 氨基酸残基的205c linker,以2C11CH1片段为主的23 氨基酸残基linker,24氨基酸残基的CBH1 linker,114氨基酸残基的ETA Ⅱ区段linker,(Gly4Ser)3及Ser2 (Gly4Ser)3linker等,均获得了有功能的双特异抗体分子。Coloma等将一种scFv直接融合表达于另一种scFvC 端或铰链区之后也获得了有功能的bis2Fv。Helfrich 等还构建了专门用于表达bisFvs的载体,可直接
Production of Monoclonal Antibody by DNA Immunization with Electroporation
DNA immunization with in vivo electroporation is an efficient alternative protocol for the production of monoclonal antibodies (mAb). Generation of mAb by DNA immunization is a novel approach to circumvent the following technical hurdles
Production of Panels of Monoclonal Antibodies by the Hybridoma Method
Since the first description by Kohler and Milstein (1 ), many variations on this method for the production of monoclonal antibodies (MAbs) have appeared (e.g., 2 –4 , and it may seem superfluous to add another. The variation
技术资料暂无技术资料 索取技术资料






